Clinical applications and progress of radionuclide imaging in neuroblastoma
10.3760/cma.j.cn321828-20221109-00339
- VernacularTitle:核素显像在神经母细胞瘤中的临床应用及进展
- Author:
Wenzhu HU
1
;
Chunxia QIN
;
Xiaoli LAN
Author Information
1. 华中科技大学同济医学院附属协和医院核医学科、湖北省分子影像重点实验室，武汉 430022
- Keywords:
Neuroblastoma;
Radionuclide imaging;
Trends
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2024;44(1):55-60
- CountryChina
- Language:Chinese
-
Abstract:
Neuroblastoma is the most common extracranial solid tumor in children. The prognosis of different stages varies greatly, and its risk staging system is completely based on imaging. Radionuclide imaging plays an important role in the diagnosis and staging of various tumors, and it is also of great significance in the early diagnosis and staging of neuroblastoma. At present, imaging agents used for neuroblastoma mainly include catecholamine receptor, glucose metabolism, somatostatin receptor, etc. This article mainly discusses the application value and research progress of these imaging agents in the diagnosis of neuroblastoma.
